Literature DB >> 12352362

Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in children.

M T El-Sherbiny1, O M Mousa, A A Shokeir, M A Ghoneim.   

Abstract

PURPOSE: We evaluate the role of transforming growth factor-beta1 (TGF-beta1) in the diagnosis and followup of children with pelviureteral junction obstruction.
MATERIALS AND METHODS: TGF-beta1 concentration was measured in renal pelvic and bladder urine samples obtained from 15 children who underwent surgery for symptomatic unilateral pelviureteral junction obstruction. Bladder urine TGF-beta1 was also measured in 11 age matched patients with dilated nonobstructed kidneys as documented by nonobstructed washout curve and half-time drainage less than 10 minutes on diuretic renography. In the obstructed group bladder urine TGF-beta1 was measured 3 months after surgery.
RESULTS: In the obstructed group mean TGF-beta1 plus or minus SD in the renal pelvic urine was 285 +/- 191 pg./mg. creatinine, or 4-fold that of bladder urine (p >0.001). Mean bladder urine TGF-beta1 was 3-fold higher in patients with upper tract obstruction than in controls (68 +/- 59 versus 22 +/- 18 pg./mg. creatinine, p <0.003). Mean bladder TGF-beta1 3 months after surgery showed a trend towards a decrease, albeit still insignificant (68 +/- 59 versus 39 +/- 31 pg./mg. creatinine for preoperatively versus postoperatively, p <0.08). Using a bladder urine concentration of 29 pg./mg. creatinine as a cutoff between obstruction and no obstruction, TGF-beta1 was 80% sensitive, 82% specific and 81% accurate for the diagnosis of obstruction.
CONCLUSIONS: Bladder urine TGF-beta1 is a useful noninvasive tool for diagnosis of upper urinary tract obstruction. At 3 months following corrective surgery there is a trend towards decrease in bladder TGF-beta1 concentration in comparison to the preoperative value.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352362     DOI: 10.1097/01.ju.0000027231.84450.8f

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

Review 1.  Congenital ureteropelvic junction obstruction: human disease and animal models.

Authors:  Julie Klein; Julien Gonzalez; Mathieu Miravete; Cécile Caubet; Rana Chaaya; Stéphane Decramer; Flavio Bandin; Jean-Loup Bascands; Bénédicte Buffin-Meyer; Joost P Schanstra
Journal:  Int J Exp Pathol       Date:  2010-07-30       Impact factor: 1.925

2.  First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction.

Authors:  Dusan Kostic; Glenda Priscila Neves Dos Santos Beozzo; Saulo Brasil do Couto; André Henrique Teruaki Kato; Laila Lima; Patricia Palmeira; Vera Lúcia Jornada Krebs; Victor Bunduki; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib; Werther Brunow de Carvalho; Vera Hermina Kalika Koch
Journal:  Pediatr Nephrol       Date:  2019-01-29       Impact factor: 3.714

3.  Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.

Authors:  Jens Drube; Petra Zürbig; Eric Schiffer; Esther Lau; Benno Ure; Sylvia Glüer; Martin Kirschstein; Lars Pape; Stéphane Decramer; Jean-Loup Bascands; Joost P Schanstra; Harald Mischak; Jochen H H Ehrich
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

4.  The role of urinary TGF-β₁, TNF-α, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves.

Authors:  Ankur Mandelia; Minu Bajpai; Sandeep Agarwala; Arun K Gupta; Rakesh Kumar; Abid Ali
Journal:  Pediatr Nephrol       Date:  2013-06-08       Impact factor: 3.714

5.  Urinary TGF-1 has a supplementary value in predicting renal function recovery post unilateral ureteral obstruction.

Authors:  Xiaoxiang Chen; Wei Zhu; Samih Al-Hayek; Xiang Yan; Chunming Jiang; Xi Zheng; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2014-10-09       Impact factor: 2.370

6.  Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies.

Authors:  Mariana A Vasconcelos; Maria Candida F Bouzada; Katia D Silveira; Leticia R Moura; Fabiana F Santos; Juliana M Oliveira; Flavia F Carvalho; Mauro M Teixeira; Ana Cristina Simões E Silva; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2011-02-18       Impact factor: 3.714

7.  Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants with pyelonephritis.

Authors:  Emmanouil Galanakis; Maria Bitsori; Helen Dimitriou; Christina Giannakopoulou; Nickolaos S Karkavitsas; Maria Kalmanti
Journal:  Int Urol Nephrol       Date:  2007-02-21       Impact factor: 2.370

8.  Non-invasive markers of ureteropelvic junction obstruction.

Authors:  Stephane Decramer; Jean-Loup Bascands; Joost P Schanstra
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

9.  Urinary biomarkers in obstructive nephropathy.

Authors:  Peter Trnka; Larissa Ivanova; Michael J Hiatt; Douglas G Matsell
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 8.237

10.  Urinary cytokine profiles in unilateral congenital hydronephrosis.

Authors:  Katarzyna Taranta-Janusz; Anna Wasilewska; Wojciech Dębek; Marlena Waszkiewicz-Stojda
Journal:  Pediatr Nephrol       Date:  2012-06-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.